Two Sigma Securities’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,354
| Closed | -$10.7K | – | 2238 |
|
|
2023
Q3 | $10.7K | Buy |
+12,354
| New | +$10.7K | ﹤0.01% | 1151 |
|
|
2023
Q2 | – | Sell |
-1,158
| Closed | -$4.29K | – | 2056 |
|
|
2023
Q1 | $4.29K | Buy |
1,158
+274
| +31% | +$1.01K | ﹤0.01% | 1241 |
|
|
2022
Q4 | $3.36K | Sell |
884
-716
| -45% | -$2.72K | ﹤0.01% | 1278 |
|
|
2022
Q3 | $13K | Buy |
+1,600
| New | +$13K | ﹤0.01% | 1156 |
|
|
2018
Q4 | – | Sell |
-123
| Closed | -$9K | – | 1794 |
|
|
2018
Q3 | $9K | Sell |
123
-19
| -13% | -$1.39K | ﹤0.01% | 1128 |
|
|
2018
Q2 | $11K | Sell |
142
-18
| -11% | -$1.39K | ﹤0.01% | 1000 |
|
|
2018
Q1 | $14K | Buy |
+160
| New | +$14K | ﹤0.01% | 1087 |
|
|
2017
Q4 | – | Sell |
-54
| Closed | -$16K | – | 1503 |
|
|
2017
Q3 | $16K | Buy |
54
+16
| +42% | +$4.74K | ﹤0.01% | 799 |
|
|
2017
Q2 | $10K | Buy |
+38
| New | +$10K | ﹤0.01% | 810 |
|
|
2017
Q1 | – | Sell |
-63
| Closed | -$38K | – | 1164 |
|
|
2016
Q4 | $38K | Buy |
+63
| New | +$38K | 0.01% | 616 |
|
|
2015
Q2 | – | Sell |
-43
| Closed | -$44K | – | 286 |
|
|
2015
Q1 | $44K | Buy |
+43
| New | +$44K | 0.05% | 155 |
|